Monogram Technologies Inc
MGRM6.000USD
0.000
Close 12/22, 16:00（ET）Quotes delayed by 15 min
216.53MMarket Cap
LossP/E TTM
More Details of Monogram Technologies Inc Company
Monogram Technologies Inc., formerly Monogram Orthopaedics Inc., is an artificial intelligence (AI)-driven robotics company focused on improving human health, with an initial focus on orthopedic surgery. The Company is developing a product solution architecture to enable patient-optimized orthopedic implants at scale by combining three-dimensional (3D) printing, advanced machine vision, AI and robotics. Its mBos precision robotic surgical system is designed to autonomously execute optimized paths for high-precision insertion of its mPress press-fit implants. The Company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures. The Company is also exploring other clinical and commercial applications for the mBos with mVision navigation.
Monogram Technologies Inc Info
Ticker SymbolMGRM
Company nameMonogram Technologies Inc
IPO dateMay 18, 2023
CEOMr. Benjamin Sexson
Number of employees27
Security typeOrdinary Share
Fiscal year-endMay 18
Address53 Bridge Street Unit 507
CityBROOKLYN
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code11201
Phone17185763205
Websitehttps://www.monogramtechnologies.com/
Ticker SymbolMGRM
IPO dateMay 18, 2023
CEOMr. Benjamin Sexson
Company Executives of Monogram Technologies Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Chris Tyson
Mr. Chris Tyson
Executive Vice President
Executive Vice President
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Chris Tyson
Mr. Chris Tyson
Executive Vice President
Executive Vice President
--
--
Revenue Breakdown
FY2024
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Zimmer Biomet Holdings, Inc.
24.01%
Icahn School of Medicine at Mount Sinai
5.81%
Pro-Dex Inc
5.44%
Tudor Investment Corporation
2.99%
The Vanguard Group, Inc.
2.36%
Other
59.39%
Shareholders
Shareholders
Proportion
Zimmer Biomet Holdings, Inc.
24.01%
Icahn School of Medicine at Mount Sinai
5.81%
Pro-Dex Inc
5.44%
Tudor Investment Corporation
2.99%
The Vanguard Group, Inc.
2.36%
Other
59.39%
Shareholder Types
Shareholders
Proportion
Holding Company
24.01%
Corporation
11.25%
Hedge Fund
4.74%
Investment Advisor
4.16%
Investment Advisor/Hedge Fund
1.32%
Research Firm
0.23%
Other
54.30%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
78
2.07M
5.09%
-53.89K
2025Q2
73
13.82M
38.22%
+160.49K
2025Q1
70
13.80M
38.67%
+170.39K
2024Q4
67
13.51M
39.38%
+322.57K
2024Q3
55
13.06M
41.28%
+264.50K
2024Q2
44
12.27M
38.78%
-449.19K
2024Q1
41
12.14M
38.38%
-162.63K
2023Q4
32
12.30M
41.64%
+1.57M
2023Q3
22
10.73M
36.66%
+319.53K
2023Q2
15
7.55M
25.82%
+7.55M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Zimmer Biomet Holdings, Inc.
9.75M
24.01%
+9.75M
--
Jul 11, 2025
Icahn School of Medicine at Mount Sinai
2.36M
5.81%
--
--
Aug 14, 2025
Pro-Dex Inc
2.21M
5.44%
+383.83K
+20.99%
Aug 14, 2025
The Vanguard Group, Inc.
1.00M
2.47%
+108.09K
+12.05%
Jun 30, 2025
Geode Capital Management, L.L.C.
243.38K
0.6%
-29.00
-0.01%
Jun 30, 2025
Susquehanna International Group, LLP
59.81K
0.15%
+4.97K
+9.05%
Jun 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares Micro-Cap ETF
0.02%
iShares Micro-Cap ETF
Proportion0.02%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of Monogram Technologies Inc?
The top five shareholders of Monogram Technologies Inc are:
Zimmer Biomet Holdings, Inc. holds 9.75M shares, accounting for 24.01% of the total shares.
Icahn School of Medicine at Mount Sinai holds 2.36M shares, accounting for 5.81% of the total shares.
Pro-Dex Inc holds 2.21M shares, accounting for 5.44% of the total shares.
The Vanguard Group, Inc. holds 1.00M shares, accounting for 2.47% of the total shares.
Geode Capital Management, L.L.C. holds 243.38K shares, accounting for 0.60% of the total shares.
Zimmer Biomet Holdings, Inc. holds 9.75M shares, accounting for 24.01% of the total shares.
Icahn School of Medicine at Mount Sinai holds 2.36M shares, accounting for 5.81% of the total shares.
Pro-Dex Inc holds 2.21M shares, accounting for 5.44% of the total shares.
The Vanguard Group, Inc. holds 1.00M shares, accounting for 2.47% of the total shares.
Geode Capital Management, L.L.C. holds 243.38K shares, accounting for 0.60% of the total shares.
What are the top three shareholder types of Monogram Technologies Inc?
The top three shareholder types of Monogram Technologies Inc are:
Zimmer Biomet Holdings, Inc.
Icahn School of Medicine at Mount Sinai
Pro-Dex Inc
Zimmer Biomet Holdings, Inc.
Icahn School of Medicine at Mount Sinai
Pro-Dex Inc
How many institutions hold shares of Monogram Technologies Inc (MGRM)?
As of 2025Q3, 78 institutions hold shares of Monogram Technologies Inc, with a combined market value of approximately 2.07M, accounting for 5.09% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -33.12%.
What is the biggest source of revenue for Monogram Technologies Inc?
In FY2024, the -- business generated the highest revenue for Monogram Technologies Inc, amounting to -- and accounting for --% of total revenue.
